Imperva Inc (IMPV) Drops 5.61% on February 05

Equities Staff |

Imperva Inc (IMPV) was one of the Russell 2000's biggest losers for Friday February 05 as the stock slid 5.61% to $39.60, a loss of $-2.355 per share. Starting at an opening price of $41.20 a share, the stock traded between $37.40 and $41.41 over the course of the trading day. Volume was 1.37 million shares over 12,385 trades, against an average daily volume of 520,058 shares and a total float of 31.43 million.

The losses send Imperva Inc down to a market cap of $1.24 billion. In the last year, Imperva Inc has traded between $77.99 and $38.20, and its 50-day SMA is currently $62.75 and 200-day SMA is $63.52.

Imperva Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. Its products include database activity monitor, database firewall, and among others.

Imperva Inc is based out of Redwood Shores, CA and has some 850 employees. Its CEO is Anthony J. Bettencourt.

For a complete fundamental analysis analysis of Imperva Inc, check out’s Stock Valuation Analysis report for IMPV. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…